|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00205 BFB HEALTH
Nominal 
0.555 +0.005 (+0.909%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 283,724 | 1702.109% | 33,117 | 30,151 | 38,379 | 73,163 |
| Cost of Sales | (164,021) | 1924.951% | (16,884) | (17,735) | (27,148) | (31,920) |
| Gross Profit | 119,703 | 1465.973% | 16,233 | 12,416 | 11,231 | 41,243 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | (1,085) | -- | -- | |
| Change in FV & Impairment on Others | 2,960 | -66.595% | (17,047) | (2,889) | (18,965) | (26,790) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (336) | 40.000% | 1,700 | (22,525) | (5,267) | (2,707) | |
| Profit / (Loss) before Taxation | 10,958 | -- | (19,568) | (29,403) | (40,465) | (87,294) | |
| Taxation | (1,193) | -- | (425) | 521 | 3,068 | (1,969) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (539) | 18.985% | 14,453 | (5,714) | 14,118 | 6,790 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 9,226 | -- | (5,540) | (34,596) | (23,279) | (82,473) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 241 | -43.692% | 1,946 | 1,844 | 1,406 | 1,339 |
| Depreciation & Amortisation | 207 | -62.568% | 427 | 1,847 | 586 | 791 |
| Directors' Emoluments | -- | -- | 586 | 1,583 | 4,109 | 1,896 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 0.800 | -- | -0.600 | -4.300 | -2.836 | -11.521 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.025) | 0.029 | (0.050) | (0.012) |
| NBV per share ($) | 0.174 | -- | 0.167 | 0.211 | 0.250 | 0.261842 |
| Remarks: | Real time quote last updated: 31/08/2026 11:48 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 9,226 |
| %Change | -- |
| EPS / (LPS) | HKD 0.008 |
| NBV Per Share ($) | HKD 0.174 |